Cargando…
CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
BACKGROUND: Programmed death-ligand 1 (PD-L1) is an immunosuppressor that plays an important role in cancer treatments. Although majority of the studies demonstrated that PD-L1 expression was regulated by cellular intrinsic and extrinsic controls, and IFN-γ was a key molecule of extrinsic control, o...
Autores principales: | Zhang, Chenlu, Li, Zhi, Xu, Ling, Che, Xiaofang, Wen, Ti, Fan, Yibo, Li, Ce, Wang, Shuo, Cheng, Yu, Wang, Xiaoxun, Qu, Xiujuan, Liu, Yunpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916585/ https://www.ncbi.nlm.nih.gov/pubmed/29690901 http://dx.doi.org/10.1186/s12885-018-4384-8 |
Ejemplares similares
-
5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
por: Zhang, Min, et al.
Publicado: (2020) -
Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
por: Zhang, Chaoxu, et al.
Publicado: (2020) -
The Chemokine Receptor CXCR4 and c-MET Cooperatively Promote Epithelial-Mesenchymal Transition in Gastric Cancer Cells
por: Cheng, Yu, et al.
Publicado: (2018) -
Leucine‐rich repeat neuronal protein‐1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL
por: Liu, Bofang, et al.
Publicado: (2019) -
PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR
por: Lv, Jinqi, et al.
Publicado: (2020)